TWO SIGMA ADVISERS, LP - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 27 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2023$41,790
+48.1%
19,900
-3.4%
0.00%
Q4 2022$28,222
+8.5%
20,600
-18.6%
0.00%
Q3 2022$26,000
-67.5%
25,300
-65.7%
0.00%
Q2 2022$80,000
+29.0%
73,671
+25.1%
0.00%
Q1 2022$62,000
-25.3%
58,900
-41.0%
0.00%
Q4 2021$83,000
+336.8%
99,900
+603.5%
0.00%
Q3 2021$19,00014,2000.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Orin Green Financial, LLC 80,000$132,8000.07%
GSA CAPITAL PARTNERS LLP 496,781$8250.07%
DENALI ADVISORS LLC 110,200$182,9320.06%
XTX Topco Ltd 83,973$139,3950.02%
CAPITAL PERFORMANCE ADVISORS LLP 25,974$43,1170.02%
State of Wyoming 41,268$68,5050.02%
HARBOUR INVESTMENT MANAGEMENT LLC 10,100$16,7660.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 158,790$263,5910.01%
Truvestments Capital LLC 3,880$6,4410.00%
Renaissance Technologies 621,100$1,0310.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders